Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
Effect of thiazolidines and biguainides on Fanconi-derived oral cavity cancer
Fanconi Anemia Research Fund, Inc.
8/1/19 → 7/31/22
Project: Research project
-
Cancer Center Support Grant
Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, L. A., Peterson, B. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/19 → 1/31/24
Project: Research project
-
Dosing Pepsin, Ritonavir and Lexiva in acute laryngeal inflammation model
7/1/20 → 12/31/20
Project: Research project
-
Phase IIB Randomized, Placebo-Controlled Trial of ACTOpl
University of Wisconsin-Madison
9/9/16 → 8/1/21
Project: Research project
-
Phase IIB Randomized, Placebo-Controlled Trial of ACTOpl
University of Wisconsin-Madison
9/9/16 → 8/1/21
Project: Research project
-
Patients with oral preneoplastic lesions and integration of dental pathology referrals
Thompson, R., Haws, J., Rhodus, N. L. & Ondrey, F. G., Jan 1 2022, In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 43, 1, 103270.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention
Rosas, R. R., Nachbor, K. M., Handley, N., Mathison, G., Wuertz, B. R., Ba'th, F. & Ondrey, F. G., Mar 2022, In: Head and Neck. 44, 3, p. 661-671 11 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
An active surveillance program in oral preneoplasia and translational oncology benefit
Archibald, H., Buryska, S. & Ondrey, F. G., Aug 2021, In: Laryngoscope investigative otolaryngology. 6, 4, p. 764-772 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions
Gutkind, J. S., Molinolo, A. A., Wu, X., Wang, Z., Nachmanson, D., Harismendy, O., Alexandrov, L. B., Wuertz, B. R., Ondrey, F. G., Laronde, D., Rock, L. D., Rosin, M., Coffey, C., Butler, V. D., Bengtson, L., Hsu, C. H., Bauman, J. E., Hewitt, S. M., Cohen, E. E. W., Chow, H. H. S. & 2 others, , Sep 8 2021, In: JCI Insight. 6, 17, e147096.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Effects of PPAR-γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies
Hall, J. A., Rusten, M., Abughazaleh, R. D., Wuertz, B., Souksavong, V., Escher, P. & Ondrey, F., Sep 1 2020, In: Head and Neck. 42, 9, p. 2542-2554 13 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations